CME Upped to Outperform - Analyst Blog
17 Agosto 2013 - 1:05AM
Zacks
On Aug 14, 2013, we upgraded derivative exchange – CME
Group Inc. (CME) to Outperform based on its improved
growth momentum, which augurs sustained long-term growth.
Why the Upgrade?
CME Group has witnessed some moderation since its second-quarter
2013 results on Aug 1. Both operating earnings of 93 cents per
share and total revenue of $816.1 million topped the Zacks
Consensus Estimate of 90 cents and $806 million, respectively,
during the second-quarter.
Both earnings and revenues exceeded the year-ago results by
25.7% and 2.5%, respectively. Overall, CME Group delivered positive
earnings surprises in all of the last 4 quarters with an average
beat of 2.4%.
A surge of 15% in average daily volume along with higher
clearing and transaction fees (accounting for about 85% of the
total revenue)boosted results, partially offset by lower average
rate per contract. Further, a 5.6% decline in operating expenses
helped operating margin rebound to its historical highs of above
60% to 62.2% from 59.0% in the year-ago quarter.
Following the release of the second-quarter results, the Zacks
Consensus Estimate for 2013 and 2014 remained intact at $3.17 and
$3.67 a share, respectively, in the last 7 days. Meanwhile, the
current estimates reflect 4.8% year over year growth in 2013 and
15.7% upsurge in 2014. With the Zacks Consensus Estimates for both
2013 and 2014 remaining steady, the company now has a Zacks Rank #3
(Hold).
What is the cause for the strong positive bias on the company?
The sustained results in the first half of 2013 have instilled
market confidence in the company. This is also reflected by the
recent upgrade in outlook to stable from negative by S&P
Ratings.
CME Group has the potential to reach new heights once the market
stabilizes with its low-risk debt profile, improved operating cash
flow and low capital expenditure. Moreover, the company’s
diversified product portfolio and strategic alliances bode well for
improving operating leverage.
Other Financial Stocks That Warrant a Look
While CME Group shows no clear directional pressure in the near
term, other outperformers of the financial sector including
MarketAxess Holdings Inc. (MKTX), Fleetcor
Tech Inc. (FLT) and Gain Capital Holdings
Inc. (GCAP) carrying a Zacks Rank #1 (Strong Buy) appear
impressive.
CME GROUP INC (CME): Free Stock Analysis Report
FLEETCOR TECH (FLT): Free Stock Analysis Report
GAIN CAP HLDGS (GCAP): Free Stock Analysis Report
MARKETAXESS HLD (MKTX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Grafico Azioni Flight Safety (AMEX:FLT)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Flight Safety (AMEX:FLT)
Storico
Da Nov 2023 a Nov 2024